404 related articles for article (PubMed ID: 26567746)
1. Microglia in Alzheimer's disease: the good, the bad and the ugly.
Tejera D; Heneka MT
Curr Alzheimer Res; 2016; 13(4):370-80. PubMed ID: 26567746
[TBL] [Abstract][Full Text] [Related]
2. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
3. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
4. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
Fan Z; Okello AA; Brooks DJ; Edison P
Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration.
Asamu MO; Oladipo OO; Abayomi OA; Adebayo AA
Brain Res; 2023 Dec; 1821():148589. PubMed ID: 37734576
[TBL] [Abstract][Full Text] [Related]
7. The Role of Microglia in Sporadic Alzheimer's Disease.
Streit WJ; Khoshbouei H; Bechmann I
J Alzheimers Dis; 2021; 79(3):961-968. PubMed ID: 33361603
[TBL] [Abstract][Full Text] [Related]
8. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
9. Microglial pathology.
Streit WJ; Xue QS; Tischer J; Bechmann I
Acta Neuropathol Commun; 2014 Sep; 2():142. PubMed ID: 25257319
[TBL] [Abstract][Full Text] [Related]
10. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
[TBL] [Abstract][Full Text] [Related]
11. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
12. Altered motility of plaque-associated microglia in a model of Alzheimer's disease.
Gyoneva S; Swanger SA; Zhang J; Weinshenker D; Traynelis SF
Neuroscience; 2016 Aug; 330():410-20. PubMed ID: 27288150
[TBL] [Abstract][Full Text] [Related]
13. Cellular aspects of the inflammatory response in Alzheimer's disease.
Kalaria RN; Cohen DL; Premkumar DR
Neurodegeneration; 1996 Dec; 5(4):497-503. PubMed ID: 9117569
[TBL] [Abstract][Full Text] [Related]
14. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.
Walter S; Letiembre M; Liu Y; Heine H; Penke B; Hao W; Bode B; Manietta N; Walter J; Schulz-Schuffer W; Fassbender K
Cell Physiol Biochem; 2007; 20(6):947-56. PubMed ID: 17982277
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease.
Shie FS; Woltjer RL
Curr Med Chem; 2007; 14(27):2865-71. PubMed ID: 18045132
[TBL] [Abstract][Full Text] [Related]
16. Microglial activation in Alzheimer's disease.
Schlachetzki JC; Hüll M
Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
[TBL] [Abstract][Full Text] [Related]
17. Microglia in Alzheimer's disease.
Li Y; Tan MS; Jiang T; Tan L
Biomed Res Int; 2014; 2014():437483. PubMed ID: 25197646
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
Regen F; Hellmann-Regen J; Costantini E; Reale M
Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
[TBL] [Abstract][Full Text] [Related]
19. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
20. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease.
Dionisio-Santos DA; Olschowka JA; O'Banion MK
J Neuroinflammation; 2019 Apr; 16(1):74. PubMed ID: 30953557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
